TITLE

NUCHEM ALLOWED MOLECULES PATENT BY EUROPEAN PATENT OFFICE

PUB. DATE
October 2003
SOURCE
Worldwide Biotech;Oct2003, Vol. 15 Issue 10, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that NuChem Pharmaceuticals Inc. has been allowed a patent for molecules that inhibit cancer progression by the European Patent Office as of October 2003.
ACCESSION #
10935575

 

Related Articles

  • Lorus Therapeutics receives European patent to protect a class of anticancer agents.  // PharmaWatch: Biotechnology;October 2003, Vol. 2 Issue 10, p21 

    Reports on the grant of a European patent to Nuchem Pharmaceuticals Inc., a subsidiary of Lorus Therapeutics Inc., covering certain molecules that inhibit cancer progression. Significance of the patent on the intellectual property portfolio of Lorus; Protection of the use of a specific class of...

  • iso/key changes.  // Chemical Week;4/27/2005, Vol. 167 Issue 14, p28 

    Reports on the promotion, selection and appointment of several chemical industry executives as of April 2005. Steve Trangluch and Frank Schlengel at Crompton; Regis Reynolds Rumpf at Nuchem and Thermal Science; Hawon Kea at Sartomer.

  • The Community Patent: Thirty Years of Planning Grinds to a Halt. Carter, Stephen // Medical Device Technology;Sep2003, Vol. 14 Issue 7, p38 

    Explores the controversies associated with the Community Patent, a unitary patent right with effect throughout Europe. Problems with the European patent system; Initial proposal of English as the language for the Community Patent; Agreement that the applicant must file translations of the...

  • Patents.  // New Orleans CityBusiness (1994 to 2008);07/21/97, Vol. 18 Issue 3, p36 

    Presents a listing of patents filed in New Orleans, Louisiana, in the `Official Gazette of the United States Patent & Trademark Office,' on May 27, 1997.

  • The value of patents. Jenkins, Matthew R.S. // Appliance Manufacturer;Oct95, Vol. 43 Issue 10, p72 

    Discusses the benefits of having a strong patent portfolio. Competitive advantage; Licensing value; Litigation value; Business value; Better employee relations.

  • Patent process puts up legal shield for firms. Molinari, Deanne // Grand Rapids Business Journal;12/08/97, Vol. 15 Issue 49, pB-1 

    Focuses on trends in patent application in Michigan. Large percentage of patents sought for electronically-based products and chemical inventions; Types of patents; Purpose of a patent; Requirement of engineering expertise on lawyers involved in the patent process.

  • VALLEY LAGS IN PATENTS. Halsey, Heather // Business Journal Serving Fresno & the Central San Joaquin Valley;2/26/2010, Issue 324146, p1 

    The article reports that Central Valley, California lags in granting patents with only 5% issued in the region of the 103,282 patents granted by the state.

  • Show, tell, and listen before you seek a patent. McKee, Bradford // Nation's Business;Sep92, Vol. 80 Issue 9, p8 

    Advises inventors on what to do before seeking a patent, from inventor and entrepreneur Gregory Lehktman. Showing the invention to others; Knowing its history; Analyzing the marketplace; Deciding when to offer a product to consumers.

  • Non-profit patents.  // New Scientist;9/12/92, Vol. 135 Issue 1838, p12 

    Reveals that Britain is losing some of its most profitable inventions because publicly funded research institutions fail to patent their discoveries. The report recommends that all staff be made aware of the importance of intellectual property right.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics